Lipid profile frequency and the prevalence of dyslipidaemia from biochemical tests at Saint Louis University Hospital in Senegal

Lipid profile frequency and the prevalence of dyslipidaemia from biochemical tests at Saint Louis University Hospital in Senegal

 

Dominique Doupa¹, Abdou Salam Mbengue², Fatou Agne Diallo³, Modou Jobe^4,&, Arame Ndiaye³, Adama Kane⁴, Alassane Diatta³, Meissa Touré³

 

¹Laboratoire de Biochimie-Biologie Moléculaire Unité de formation et de recherche (UFR), Santé Université Gaston Berger, Saint Louis, Sénégal, ²Laboratoire de Bactériologie-Virologie, CHU Aristide Le Dantec, Dakar, Sénégal, ³Laboratoire de Biochimie-Biologie Moléculaire, Faculté de Médecine, de Pharmacie et d’Odontologie de l’Université Cheikh Anta Diop, Dakar, Sénégal, ⁴Service de cardiologie, CHU Aristide Le Dantec, Dakar, Sénégal

 

 

^&Corresponding author
Dr. Modou Jobe, Service de cardiologie, CHU Aristide Le Dantec, BP 3001, Dakar, Senegal.

 

 

 

 

In Africa, death from chronic noncommunicable diseases (NCDs) and its complications far exceed that of AIDS, malaria and tuberculosis combined [1]. It is estimated that over the next decade, these will be higher than those for all communicable diseases [2]. Among the chronic NCDs, cardiovascular diseases remain the leading cause of death and disability in developed countries, and increasingly in developing countries. They are a major cause of premature mortality, morbidity and high healthcare costs. They have an important impact in terms of public health and most of them are the result of clinical complications secondary to atherosclerotic lesions of the arteries. Among the primary risk factors, the Framingham study has shown the important role of lipids and especially of hypercholesterolaemia in causing lesions [3]. In Senegal, as in most of sub-Saharan Africa, there are few data on the epidemiology of dyslipidaemia across the population. The objectives of this study were to evaluate the frequency of requests for lipid profile and the prevalence of dyslipidaemia in patients at the biochemistry laboratory of St. Louis University Hospital in Senegal from January to June 2013.

 

 

This was a retrospective study conducted from January to June 2013 from laboratory requests and involving 14, 116 patient results at the biochemistry laboratory of St. Louis University Hospital (a national referral hospital) regardless of the indication for the biochemical tests. Patients whose results were included in the laboratory register were included regardless of the number of lipid parameters that were included in the analysis report.

 

Serum assays for lipid parameters such as total cholesterol, HDL-cholesterol and triglycerides were performed by standard enzymatic methods using an automatic multiparametric analyser (Cobas Integra, Roche) and BTS-310 (Biosystems) and the results expressed in (g/l). Serum concentrations of LDL-cholesterol were obtained by calculation according to the Friedewald method [4]. When triglyceride levels exceeded 3.4 g/l, LDL was not determined. The standards held in this laboratory are therefore high and meeting those held internationally.

 

Operational definition of variables

 

The values used to define dyslipidemia are those of the National Educational Program (NECP) [5]. Hypercholesterolaemia: Total cholesterol >2g/l (5.2mmol/L). HypoHDLaemia: HDL- Cholesterol <0.40g/l (1.04mmol/L). Hypertriglyceridaemia: Triglycerides >1.50g/l (1.69mmol/L). Mixed hyperlipidaemia: Total cholesterol >2g/l (5.2mmol/L) and triglycerides >1.50g/l (1.69mmol/L). HyperLDLaemia: LDL-cholesterol >1.3g/l (3.1mmol/L)

 

Statistical analysis

 

All data were analyzed with Epi Info7 software (CDC, Atlanta). Quantitative variables were expressed as mean with standard deviation. Qualitative variables were expressed as numbers and percentages. The chi-square test and Fisher's exact test were used to explain the relationship between two variables. The difference was considered to be statistically significant when p <0.05. All analysis were performed with a 95% confidence interval.

 

 

1329 patients were included in our study including 499 men (37.5% of the sample) and 830 women (62.5% of the sample) giving a sex ratio (M/ F) of 0.60. The average age of the population was 55.15 years, ranging from 2 to 96 years. The general characteristics of the study population are summarized in Table 1. The age group most represented was that between 55 to 65 years (Figure 1). In our study population, 9% (1329/14116) had at least a request for lipid profile as part of the biochemical investigations. The respective prevalence of hypercholesterolaemia, hyperLDLaemia, HypoHDLaemia hypertriglyceridaemia and mixed hyperlipidaemia were 60.91%, 66.27%, 26.58%, 4.57% and 2.75% (Table 2). Hypercholesterolemia, hyperLDLaemia, hypertriglyceridaemia and mixed hyperlipidaemia were higher in women with respectively 66.22%, 67.98%, 4.58%, and 2.89% compared to men with respectively 52.01%, 62.81%, 4.44% and 2.40%. On the other hand, the prevalence of HypoHDLaemia was greater in males (32.19%) than females (23.76%) (Figure 2).

 

Table 3 shows the risk factors associated with the types of dyslipidaemia. Hypercholesterolaemia, hyperLDLaemia and hypoHDLaemia correlated significantly with sex (p<0.05). Hypercholesterolaemia was the only type that significantly and positively correlated with age in this study.

 

 

Senegal, like most developing countries is experiencing an epidemiological transition. The latest statistics released by the demographic and health survey (EDSIV 2005) [6] showed that 22% of women in Senegal have a high BMI being either overweight or obese. This study which was aimed at determining the frequency of request for lipid profile and the prevalence of dyslipidaemia over a six-month period showed 1329 patients out of 14,116 (being 9% of requests) having biochemical test for lipid profile from the University Hospital of Saint-Louis. In a similar study conducted at the biochemistry laboratory of the University Hospital of Cocody in Ivory Coast, Tiahou G et al in 2010 [7] found a frequency of 5.7% of request for lipid profile. In this study, this low prescribing of lipid profile was attributed partly to the low qualification level of prescribers and also the lack of proper equipments suitable for the production of certain specialised exams. This relatively higher frequency of requests for lipid profile in our study is due in large part to the existence of a specialized care unit for cardiovascular disease and qualification level of prescribers (a cardiologist and two internists).

 

In socio-demographic terms we noted a female predominance (sex ratio male / female) 0.60, slightly higher than the last census in St. Louis [8]. This imbalance could be explained by the large male migration to the capital [8]. The average age of our study population was 55.15 ± 16.2 years. Two other studies have found similar results including that of Essais et al in the Tunisian population [9] and that of Yousef in the Jordanian population [10].

 

Our study revealed a high prevalence of dyslipidaemia. Of a total of 1329 patients, 60.91% had hypercholesterolemia, 66.27% with hyperLDLaemie, 26.58% with hypoHDLaemie, 4.57% with hypertriglyceridaemia and 2.75% with mixed hyperlipidaemia. Furthermore, hypercholesterolaemia, hypoHDLaemia, hypertriglyceridaemia and mixed hyperlipidaemia were higher among females compared to their male counterparts. On the other hand hypoHDLaemia was higher in men. A study conducted in Jordan by Khader et al in 2010 [10] found a prevalence of 48.3% of hypercholesterolemia, 40.1% of HypoHDLaemia, 40.7% of HyperLDLaemia, 43.6% of Hypertriglyceridaemia. According to these authors the prevalence of dyslipidaemia except for hypercholesterolaemia was higher among women than among men. Our results are also similar to those of Pessinaba et al in 2013 [11] in the population Dagana (Senegal) where a high prevalence of dyslipidemia was also found in women.

 

In our study, hyperLDLaemia was the most common lipid abnormality. This result is similar to that of Erem C et al in Turkey [12] who found a predominance of hyperLDLaemia in the study population. On the other hand, Tiahou G et al in their study found hypercholesterolemia as the most lipid abnormality.

 

Our study also found that hypercholesterolaemia was significantly associated with age and sex (p <0.01 Table 3). A recent study conducted in Pakistan by Zahid N et al [13] showed that all dyslipidaemia except hypoHDLaemia correlated statistically significant to age and sex. Similar results were reported by Erem et al in Turkey. However, in our study only hypercholesterolaemia was significantly associated with age and sex. This slight difference may be explained in part by the inclusion criteria for patients, since in these two studies, only patients aged 25 years and older were included but then shows the weakness of our sampling.

 

 

This study revealed a high prevalence of dyslipidaemia despite low requesting for lipid profile at Saint Louis University Hospital. A national survey is needed to better assess the prevalence of dyslipidemia in the Senegalese population. Meanwhile, awareness of risk is necessary and should lead to the establishment of a prevention program.

 

 

The authors declare that they have no competing interests.

 

 

DD, ASM and FAD designed the study protocol, participated in the data collection and contributed in analyzing the data and writing of the draft manuscript. MJ, AN and AK participated in data analysis and critically revising the manuscript for important intellectual content. AD and MT participated in study design and in data analysis. All authors have read and approved the final version of the manuscript.

 

 

Table 1: General characteristics of the population studied

Table 2: Distribution of patients according to the type of dyslipidaemia

Table 3: Relationship with dyslipidaemia with age and sex

Figure 1: Population distribution according to age

Figure 2: Distribution of dyslipidaemia according to sex

 

 

1. Facing the facts: the impact of chronic disease in Africa. 2005. Genève, Organisation mondiale de la Santé. http://www.who.int/chp/chronic_disease_report/media/AFRO.pdf. Accessed 9th November, 2013.


2. Murray CJL, Lopez AD. The global burden of disease. A comprehensive assessment of mortality and disability from diseases, injures, and risk factors in 1990 and projected to 2020. 1996. Boston. Harvard University Press. Google Scholar


3. Anderson K, Castelli W, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987; 257(16):2176-2180. PubMed | Google Scholar


4. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. PubMed | Google Scholar


5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. PubMed | Google Scholar


6. Ndiaye S, Ayad M. Enquête démographique et de santé au Sénégal (EDSIV), Ministère de la santé et de la Prévention Médicale. 2005. Sénégal: Dakar. Centre de recherche pour le développement Humain. PubMed | Google Scholar


7. Tiahou G, Deret K, Monde A. Fréquence des bilans lipidiques et prévalence des dyslipidémies au laboratoire de Biochimie du CHU de Cocody. Jsci pharm Biol. 2010. 11(2):60-65. PubMed | Google Scholar


8. Agence Nationale de la Statistique et de la Démographie (ANSD). Situation Economique et Sociale du Sénégal 2008. 2009. Senegal: Dakar. ANSD. Google Scholar


9. Essais O, Jabrane J, Bouguerra R, El Atti J, et al. Distribution et prévalence des dyslipidémies en Tunisie: Résultats de l'enquète nationale de nutrition. La Tunisie Medicale. 2009; 87(8):505- 510. PubMed | Google Scholar


10. Khader YS, Batieha A, El-Khateeb M, Al Omari M, Ajlouni K. Prevalence of dyslipidemia and its associated factors among Jordanian adults. Journal of Clinical Lipidology. 2010; 4(1):53-58. PubMed | Google Scholar


11. Pessinaba S, Mbaye A, Yabéta GAD, Harouna H, et al. Enquête de prévalence des facteurs de risque cardiovasculaire en population générale à Saint-Louis (Sénégal). Ann Cardiol Angeiol. 2013; 62(4): 253-258. PubMed | Google Scholar


12. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemias and associated risk factors among Turkish adults: Trabzon Lipid Study. Endocrine. 2008; 34(1-3):36-51. PubMed | Google Scholar


13. Zahid N, Claussen B, Hussain A. High prevalence of obesity, dyslipidemias and metabolic syndrome in a rural area in Pakistan. Diabetes Metabol Syndr. 2008; 2(1):13-19. PubMed | Google Scholar